The Parathyroid Glands
Hyperthyroidism II: Pathophysiology
Skeleton and Calcium Homeostasis
Hormones and Bone Tissue
Graves Disease II: Pathophysiology
Hyperthyroidism I: Introduction
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 16, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Guillermo Martínez Díaz-Guerra1, Sonsoles Guadalix Iglesias, Federico Hawkins Carranza
1Servicio de Endocrinología y Nutrición, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, España. gmartinezd.hdoc@salud.madrid.org
Normocalcemic primary hyperparathyroidism is a newly recognized condition where parathyroid hormone levels are high, but calcium levels remain normal. This condition is often asymptomatic and can be difficult to distinguish from secondary causes. The review highlights the importance of accurate laboratory testing and identifying subtle signs like kidney stones or osteoporosis. Management is not yet standardized, and clinicians must consider individual patient profiles to decide on a conservative or interventionist approach.
Area of Science:
Background:
Normocalcemic primary hyperparathyroidism is increasingly recognized in clinical practice. Prior research has shown that primary hyperparathyroidism typically involves elevated serum calcium levels. However, this variant presents with normal calcium despite elevated parathyroid hormone. No prior work had resolved how to distinguish this condition from secondary hyperparathyroidism. This uncertainty has led to confusion in diagnosis and management. Clinicians may overlook normocalcemic cases due to the absence of classic symptoms. The lack of specific guidelines has created a diagnostic challenge. This gap motivated a review of current evidence to clarify clinical implications. That uncertainty drove the need for a structured analysis of diagnostic and management strategies.
Purpose Of The Study:
This review aims to clarify the clinical features and management of normocalcemic primary hyperparathyroidism. The specific problem lies in distinguishing this condition from secondary causes. The motivation stems from the lack of established diagnostic criteria. No prior work had resolved how to interpret normal calcium with elevated parathyroid hormone. The authors propose that a proper laboratory approach is essential. They emphasize the importance of identifying subtle signs like kidney stones or osteoporosis. This focus helps clinicians decide between conservative or interventionist approaches. The review seeks to guide diagnosis and treatment in this emerging condition.
Main Methods:
The authors synthesized evidence from published literature on normocalcemic primary hyperparathyroidism. They reviewed clinical features, diagnostic challenges, and management strategies. No prior work had resolved the natural history of this condition. The approach included evaluating laboratory parameters and clinical signs. They analyzed data on parathyroid hormone levels and calcium status. The study did not involve new experiments or patient data. Instead, it relied on a comprehensive literature review. The synthesis emphasized distinguishing this condition from secondary causes.
Main Results:
Key findings suggest that normocalcemic primary hyperparathyroidism is often asymptomatic. The condition is marked by elevated parathyroid hormone with normal calcium levels. No prior work had resolved the progression patterns of this disease. Some cases may remain stable without progressing to hypercalcemia. Laboratory confirmation is crucial for accurate diagnosis. Kidney stones and osteoporosis are associated clinical features. The review highlights the need for careful assessment of these signs. These findings suggest that management should be individualized based on clinical indicators.
Conclusions:
The authors propose that normocalcemic primary hyperparathyroidism requires careful laboratory diagnosis. They suggest that clinicians consider this condition in cases of elevated parathyroid hormone. The review emphasizes the importance of identifying associated symptoms like kidney stones. No prior work had resolved the optimal management strategy for this condition. The authors propose that management should be tailored to individual patient profiles. They suggest that a conservative approach may be appropriate in asymptomatic cases. The review concludes that further research is needed to clarify diagnostic and therapeutic guidelines. These findings suggest the need for standardized diagnostic and management protocols.
It is a condition where parathyroid hormone is elevated, but serum calcium remains normal, often without symptoms.
Diagnosis requires measuring intact parathyroid hormone levels while confirming normal total and ionized calcium.
Kidney stones may indicate parathyroid dysfunction despite normal calcium levels, guiding clinical decisions.
Classic cases involve elevated calcium; normocalcemic cases maintain normal calcium despite high parathyroid hormone.
Osteoporosis and kidney stones are possible signs, even when calcium levels are within normal ranges.
The authors suggest a tailored approach, possibly conservative, based on individual symptoms and diagnostic findings.